Attention deficit hyperactivity disorder and substance misuse: an evaluation of causal hypotheses and treatment considerations

References

• Manuzza S, Klein R, Bessler A, et al. Adult outcome of hyperactive boys: educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 1993;50:565-76
   PubMed Web of Science ®Google Scholar
• Chang Z, Lichtenstein P, Larsson H. The effects of childhood ADHD symptoms on early-onset substance use: a Swedish twin study. J Abnorm Child Psychol 2012;40(3):425-35
   PubMed Web of Science ®Google Scholar
• Molina BS, Pelham WE. Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Psychol 2003;112(3):497-507
   PubMed Web of Science ®Google Scholar
• Szobot CM, Rohde LA, Bukstein O, et al. Is attention-deficit/hyperactivity disorder associated with illicit substance use disorders in male adolescents? a community-based case-control study. Addiction 2007;102(7):1122-30
   PubMed Web of Science ®Google Scholar
• van Emmerik-van Oortmerssen K, van de Glind G, van den Brink W, et al. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend 2012;122(1-2):11-19
   PubMed Web of Science ®Google Scholar
• Upadhyaya HP, Rose K, Wang W, et al. Attention deficit/hyperactivity disorder, medication treatment, and substance use patterns among adolescents and young adults. J Child Adolesc Psychopharmacol 2005;15(5):799-809
   PubMed Web of Science ®Google Scholar
• Levin ED, Conners CK, Sparrow E, et al. Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology 1996;123(1):55-63
   PubMed Web of Science ®Google Scholar
• Tarter RE, Kirisci L, Habeych M, et al. Neurobehavior disinhibition in childhood predisposes boys to substance use disorder by young adulthood: direct and mediated etiologic pathways. Drug Alcohol Depend 2004;73(2):121-32
   PubMed Web of Science ®Google Scholar
• Biederman J, Wilens T, Mick E, et al. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): Effects of ADHD and psychiatric comorbidity. Am J Psychiatry 1995;152(11):1652-8
   PubMed Web of Science ®Google Scholar
• Lambert NM, Hartsough C. Prospective study of tobacco smoking and substance dependencies among sample of adhd and non-adhd participants. J Learn Disabil 1998;31(6):533-44
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Biederman J, Madras BK, et al. In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter. Biol Psychiatry 2005;57(11):1293-300
   PubMed Web of Science ®Google Scholar
• Silva NJr, Szobot CM, Shih MC, et al. Searching for a neurobiological basis for self-medication theory in ADHD comorbid with substance use disorders: An in vivo study of dopamine transporters using 99mTc-TRODAT-1 SPECT. Clin Nucl Med 2014;39(2):e129-34
   PubMed Web of Science ®Google Scholar
• Gudjonsson GH, Sigurdsson JF, Sigfusdottir ID, Young S. An epidemiological study of ADHD symptoms among young persons and the relationship with cigarette smoking, alcohol consumption and illicit drug use. J Child Psychol Psychiatry 2012;53(3):304-12
   PubMed Web of Science ®Google Scholar
• Upadhyaya HP, Carpenter MJ. Is attention deficit hyperactivity disorder (ADHD) symptom severity associated with tobacco use? Am J Addict 2008;17(3):195-8
   PubMed Web of Science ®Google Scholar
• Ashare RL, Hawk LWJr. Effects of smoking abstinence on impulsive behavior among smokers high and low in ADHD-like symptoms. Psychopharmacology (Berl) 2012;219(2):537-47
   PubMed Web of Science ®Google Scholar
• Conners CK, Erhardt D, Sparrow MA. Conners’ adult ADHD rating scales (CAARS). Multihealth Systems, Inc; New York: 1999
   Google Scholar
• Wilens TE, Adamson J, Sgambati S, et al. Do individuals with ADHD self-medicate with cigarettes and substances of abuse? Results from a controlled family study of ADHD. Am J Addict 2007;16(Suppl 1):14-23
   PubMed Web of Science ®Google Scholar
• Horner BR, Scheibe KE. Prevalence and implications of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse. J Am Acad Child Adolesc Psychiatry 1997;36(1):30-6
   PubMed Web of Science ®Google Scholar
• Faraone SV, Kunwar A, Adamson J, Biederman J. Personality traits among ADHD adults: implications of late-onset and subthreshold diagnoses. Psychol Med 2009;39(4):685-93
   PubMed Web of Science ®Google Scholar
• Biederman J, Monuteaux MC, Doyle AE, et al. Impact of executive function deficits and attention-deficit/hyperactivity disorder (ADHD) on academic outcomes in children. J Consult Clin Psychol 2004;72(5):757-66
   PubMed Web of Science ®Google Scholar
• Young S, Morris R, Toone B, Tyson C. Planning ability in adults with attention-deficit/hyperactivity disorder. Neuropsychology 2007;21(5):581-9
   PubMed Web of Science ®Google Scholar
• Baird AA, Fugelsang JA. The emergence of consequential thought: Evidence from neuroscience. Philos Trans R Soc Lond B Biol Sci 2004;359(1451):1797-804
   PubMed Web of Science ®Google Scholar
• Rose E, Bramham J, Young S, et al. Neuropsychological characteristics of adults with comorbid ADHD and borderline/mild intellectual disability. Res Dev Disabil 2009;30(3):496-502
   PubMed Web of Science ®Google Scholar
• Xenitidis K, Paliokosta E, Pappas V, Bramham J. ADHD in adults with intellectual disabilities. In: Buitelaar JK, Kan CC, Asherson P, Editors. ADHD in adults: characterization, diagnosis, and treatment. Cambridge University Press, Cambridge; New York; 2011. p. 168-73
   Google Scholar
• Wood AC, Rijsdijk F, Asherson P, Kuntsi J. Inferring causation from cross-sectional data: examination of the causal relationship between hyperactivity-impulsivity and novelty seeking. Front Genet 2011;2:6
   Google Scholar
• Young SE, Stallings MC, Corley RP, et al. Genetic and environmental influences on behavioural disinhibition. Am J Med Genet 2000;96:684-95
   PubMed Web of Science ®Google Scholar
• Smith DG, Jones PS, Bullmore ET, et al. Cognitive control dysfunction and abnormal frontal cortex activation in stimulant drug users and their biological siblings. Transl Psychiatry 2013;3:e257
   Web of Science ®Google Scholar
• Young S, Bramham J, Tyson C, Morris R. Inhibitory dysfunction on the Stroop in adults diagnosed with attention deficit hyperactivity disorder. Personal Individ Diff 2006;41(8):1377-84
   Web of Science ®Google Scholar
• Elton A, Young J, Smitherman S, et al. Neural network activation during a stop-signal task discriminates cocaine-dependent from non-drug-abusing men. Addict Biol 2014;19(3):427-38
   PubMed Web of Science ®Google Scholar
• Ersche KD, Turton AJ, Pradhan S, et al. Drug addiction endophenotypes: Impulsive versus sensation-seeking personality traits. Biol Psychiatry 2010;68(8):770-3
   PubMed Web of Science ®Google Scholar
• Handley ED, Chassin L, Haller MM, et al. Do executive and reactive disinhibition mediate the effects of familial substance use disorders on adolescent externalizing outcomes? J Abnorm Psychol 2011;120(3):528-42
   PubMed Web of Science ®Google Scholar
• Wilens TE, Martelon M, Fried R, et al. Do executive function deficits predict later substance use disorders among adolescents and young adults? J Am Acad Child Adolesc Psychiatry 2011;50(2):141-9
   PubMed Web of Science ®Google Scholar
• Palmer RHC, Knopik VS, Rhee SH, et al. Prospective effects of adolescent indicators of behavioral disinhibition on DSM-IV alcohol, tobacco, and illicit drug dependence in young adulthood. Addict Behave 2013;38(9):2415-21
   PubMed Web of Science ®Google Scholar
• Fayyad J, De Graaf R, Kessler R, et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 2007;190:402-9
   PubMed Web of Science ®Google Scholar
• Jensen PS, Hinshaw SP, Kraemer HC, et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry 2001;40(2):147-58
   PubMed Web of Science ®Google Scholar
• Pliszka SR. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview. J Clin Psychiatry 1998;59(Suppl 7):50-8
   PubMed Web of Science ®Google Scholar
• Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006;163(4):716-23
   PubMed Web of Science ®Google Scholar
• van Emmerik-van Oortmerssen K, van de Glind G, Koeter MW, et al. Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study. Addiction 2014;109(2):262-72
   PubMed Web of Science ®Google Scholar
• August GJ, Winters KC, Realmuto GM, et al. Prospective study of adolescent drug use among community samples of ADHD and non-ADHD participants. J Am Acad Child Adolesc Psychiatry 2006;45(7):824-32
   PubMed Web of Science ®Google Scholar
• Barkley RA, Fischer M, Smallish L, Fletcher K. Young adult follow-up of hyperactive children: antisocial activities and drug use. J Child Psychol Psychiatry 2004;45(2):195-211
   PubMed Web of Science ®Google Scholar
• Serra-Pinheiro MA, Coutinho ES, Souza IS, et al. Is ADHD a risk factor independent of conduct disorder for illicit substance use? a meta-analysis and metaregression investigation. J Atten Disord 2013;17(6):459-69
   PubMed Web of Science ®Google Scholar
• Sousa NO, Grevet EH, Salgado CA, et al. Smoking and ADHD: an evaluation of self medication and behavioral disinhibition models based on comorbidity and personality patterns. J Psychiatr Res 2011;45(6):829-34
   PubMed Web of Science ®Google Scholar
• Gudjonsson GH, Sigurdsson JF, Eyjolfsdottir GA, et al. The relationship between satisfaction with life, ADHD symptoms, and associated problems among university students. J Atten Disord 2009;12(6):507-15
   PubMed Web of Science ®Google Scholar
• Bizzarri JV, Rucci P, Sbrana A, et al. Reasons for substance use and vulnerability factors in patients with substance use disorder and anxiety or mood disorders. Addict Behav 2007;32(2):384-91
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence. Attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults. NICE clinical guideline 72; London: 2009
   Google Scholar
• Steketee JD, Kalivas PW. Drug wanting: behavioral sensitization and relapse to drug-seeking behavior. Pharmacol Rev 2011;63(2):348-65
   PubMed Web of Science ®Google Scholar
• Lambert NM, McLeod M, Schenk S. Subjective responses to initial experience with cocaine: an exploration of the incentive-sensitization theory of drug abuse. Addiction 2006;101(5):713-25
   PubMed Web of Science ®Google Scholar
• Wilens TE, Faraone SV, Biederman J, Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? a meta-analytic review of the literature. Pediatrics 2003;111(1):179-85
   PubMed Web of Science ®Google Scholar
• Biederman J, Wilens T, Mick E, et al. Pharamacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics 1999;104(2):20-4
   PubMed Web of Science ®Google Scholar
• Wilens TE, Adamson J, Monuteaux MC, et al. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents. Arch Pediatr Adolesc Med 2008;162(10):916-21
   PubMed Web of Science ®Google Scholar
• Manuzza S, Klein RG, Truong NL, et al. Age of methylphenidate treatment initiation in children with adhd and later substance abuse: prospective follow-up into adulthood. Am J Psychiatry 2008;165(5):604-9
   PubMed Web of Science ®Google Scholar
• Barkley RA, Fischer M, Smallish L, Fletcher K. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? a 13-year prospective study. Pediatrics 2003;111(1):97-109
   PubMed Web of Science ®Google Scholar
• Biederman J, Monuteaux MC, Spencer T, et al. Stimulant therapy and risk for subsequent substance use disorders in male adults with adhd: a naturalisitic controlled 10-year follow-up study. Am J Psychiatry 2008;165(5):597-603
   PubMed Web of Science ®Google Scholar
• Molina BS, Hinshaw SP, Eugene Arnold L, et al. Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (adhd) (mta) as a function of childhood adhd, random assignment to childhood treatments, and subsequent medication. J Am Acad Child Adolesc Psychiatry 2013;52(3):250-63
   PubMed Web of Science ®Google Scholar
• Faraone SV, Glatt SJ. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry 2010;71(6):754-63
   PubMed Web of Science ®Google Scholar
• Koesters M, Becker T, Kilian R, et al. Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder. J Psychopharmacol 2009;23(7):733-44
   PubMed Web of Science ®Google Scholar
• Bolea-Alamanac B, Nutt DJ, Adamou M, et al. Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British association for psychopharmacology. J Physchopharmacol 2014;28(3):179-203
   PubMed Web of Science ®Google Scholar
• Levin FR, Evans SM, McDowell DM, et al. Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder. J Addict Dis 2002;21(2):1-16
   PubMed Web of Science ®Google Scholar
• Ginsberg Y, Lindefors N. Methylphenidate treatment of adult male prison inmates with attention-deficit hyperactivity disorder: randomised double-blind placebo-controlled trial with open-label extension. Br J Pyschiatry 2012;200(1):68-73
   PubMed Web of Science ®Google Scholar
• Konstenius M, Jayaram-Lindstrom N, Beck O, Franck J. Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend 2010;108(1-2):130-3
   PubMed Web of Science ®Google Scholar
• Kollins SH, English JS, Itchon-Ramos N, et al. A pilot study of lis-dexamfetamine dimesylate (LDX/SPD489) to facilitate smoking cessation in nicotine-dependent adults with ADHD. J Atten Disord 2014;18(2):158-68
   PubMed Web of Science ®Google Scholar
• Winhusen TM, Somoza EC, Brigham GS, et al. Impact of attention-deficit/hyperactivity disorder (adhd) treatment on smoking cessation intervention in adhd smokers: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2010;71(12):1680-8
   PubMed Web of Science ®Google Scholar
• Bolea-Alamañac B, Nutt DJ, Adamou M, et al. Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the british association for psychopharmacology. J Psychopharmacol 2014;28(3):179-203
   PubMed Web of Science ®Google Scholar
• Wilens TE, Adler LA, Weiss MD, et al. Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend 2008;96(1–2):145-54
   PubMed Web of Science ®Google Scholar
• Thurstone C, Riggs PD, Salomonsen-Sautel S, Mikulich-Gilbertson SK. Randomized, controlled trial of atomoxetine for attention-deficit/hyperactivity disorder in adolescents with substance use disorder. J Am Acad Child Adolesc Psychiatry 2010;49(6):573-82
   PubMed Web of Science ®Google Scholar
• McRae-Clark AL, Carter RE, Killeen TK, et al. A. placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder. Am J Addict 2010;19(6):481-9
   PubMed Web of Science ®Google Scholar
• Cunill R, Castells X, Tobias A, Capella D. Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence. J Psychopharmacol 2015;29(1):15-23
   PubMed Web of Science ®Google Scholar
• Konstenius M, Jayaram-Lindstrom N, Guterstam J, et al. Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial. Addiction 2014;109(3):440-9
   PubMed Web of Science ®Google Scholar
• Riggs PD, Winhusen T, Davies RD, et al. Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders. J Am Acad Child Adolesc Psychiatry 2011;50(9):903-14
   PubMed Web of Science ®Google Scholar
• Schubiner H, Downey KK, Arfken CL, et al. Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol 2002;10(3):286-94
   PubMed Web of Science ®Google Scholar
• Young S, Bramham J. Cognitive-behavioural therapy for ADHD in adolescents and adults: a psychological guide to practice. Wiley-Blackwell; Sussex, UK: 2012
   Google Scholar
• Levin FR, Evans SM, Brooks DJ, Garawi F. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo. Drug Alcohol Depend 2007;87(1):20-9
   PubMed Web of Science ®Google Scholar
• Gordon MS, Kinlock TW, Battjes RJ. Correlates of early substance use and crime among adolescents entering outpatient substance abuse treatment. Am J Drug Alcohol Abuse 2004;30(1):39-59
   PubMed Web of Science ®Google Scholar
• Young S, Wells J, Gudjonsson GH. Predictors of offending among prisoners: the role of attention-deficit hyperactivity disorder and substance use. J Psychopharmacol 2011;25(11):1524-32
   PubMed Web of Science ®Google Scholar
• Young S, Moss D, Sedgwick O, et al. A meta-analysis of the prevalence of attention deficit hyperactivity disorder in incarcerated populations. Psychol Med 2014. [Epub ahead of print]
   Web of Science ®Google Scholar
• Young S, Sedgwick O, Fridman M, et al. Comorbid psychiatric disorders amongst incarcerated ADHD populations: a meta-analysis. Psychol Med 2015; Epub ahead of print
   Google Scholar
• Young S, Gudjonsson GH, Wells J, et al. Attention deficit hyperactivity disorder and critical incidents in a Scottish prison population. Pers Individ Dif 2009;46(3):265-9
   Web of Science ®Google Scholar
• Young S, Goodwin EJ, Sedgwick O, Gudjonsson GH. The effectiveness of police custody assessments in identifying suspects with intellectual disabilities and attention deficit hyperactivity disorder. BMC Med 2013;11(1):248
   PubMed Web of Science ®Google Scholar
• Gordon V, Williams DJ, Donnelly PD. Exploring the relationship between ADHD symptoms and prison breaches of discipline amongst youths in four Scottish prisons. Public Health 2012;126(4):343-8
   PubMed Web of Science ®Google Scholar
• Schubert CA, Mulvey EP, Glasheen C. Influence of mental health and substance use problems and criminogenic risk on outcomes in serious juvenile offenders. J Am Acad Child Adolesc Psychiatry 2011;50(9):925-37
   PubMed Web of Science ®Google Scholar
• Huntley Z, Maltezos S, Williams C, et al. Rates of undiagnosed attention deficit hyperactivity disorder in London drug and alcohol detoxification units. BMC Psychiatry 2012;12:223
   PubMed Web of Science ®Google Scholar
• Hodgins S, Larm P, Molero-Samuleson Y, et al. Multiple adverse outcomes over 30 years following adolescent substance misuse treatment. Acta Psychiatr Scand 2009;119(6):484-93
   PubMed Web of Science ®Google Scholar
• Huntley Z, Young S. Alcohol and substance use history among ADHD. adults: the relationship with persistent and remitting symptoms, personality, employment, and history of service use. J Atten Disord 2014;18(1):82-90
   PubMed Web of Science ®Google Scholar